Measles Vaccination Schedule: CDC Timeline & Catch-Up (2026)

By Sarah Mitchell · February 11, 2026

Why This Timing Question Matters More Than Ever

When do kids get vaccinated for measles is one of the most urgent and frequently asked questions among parents today — especially as measles cases surge across the U.S. and globally. In 2024 alone, the CDC confirmed over 170 measles cases in 23 states — the highest number since 2019 — with more than 85% occurring in unvaccinated or under-vaccinated children. That’s not just a statistic; it’s a wake-up call. Getting the timing right isn’t about checking a box — it’s about aligning with your child’s developing immune system, maximizing protection during their most vulnerable early years, and contributing to community immunity that shields infants too young for vaccines and immunocompromised peers. This guide walks you through exactly when, why, and how measles vaccination works — backed by AAP guidelines, CDC data, and real-world clinical insights from pediatric infectious disease specialists.

The Standard MMR Schedule: When & Why It’s Designed This Way

The measles, mumps, and rubella (MMR) vaccine is one of the safest and most effective vaccines ever developed — with two doses providing 97% protection against measles. But its power depends entirely on timing. The CDC’s recommended schedule isn’t arbitrary; it’s calibrated to three biological and epidemiological realities: infant maternal antibody interference, immune system maturation, and outbreak risk windows.

Here’s how it breaks down:

Dose 1 at 12–15 months: Maternal antibodies (passed via placenta and breast milk) typically wane by this age — but linger long enough before then to block vaccine effectiveness. Giving MMR before 12 months rarely produces lasting immunity. A dose at 12 months strikes the optimal balance: low maternal antibody interference + sufficient immune maturity.
Dose 2 at 4–6 years: This ‘booster’ isn’t because the first dose failed — it’s because ~3% of children don’t seroconvert after dose one. The second dose ensures near-universal protection just before school entry, when exposure risk spikes dramatically in classrooms and cafeterias.

Dr. Elena Torres, a pediatric infectious disease specialist at Children’s National Hospital and co-author of the AAP’s 2023 Immunization Handbook update, explains: “We don’t delay dose one to ‘wait for immunity’ — we wait to avoid wasting a dose that won’t stick. And we don’t give dose two earlier just to ‘get it done’ — we time it to close the last immunity gap before high-density social exposure.”

What If Your Child Missed a Dose? The Catch-Up Protocol You Need to Know

Missed doses happen — whether due to illness, moving between providers, pandemic disruptions, or vaccine hesitancy. The good news? There’s no ‘too late’ for MMR. Unlike some vaccines, MMR has no upper age limit for catch-up, and prior doses don’t need repeating — even if given outside the ideal window.

Here’s how to navigate it:

Check your records first: Don’t assume. Request official immunization records from your state’s immunization registry (like CAIR in California or MIIS in Michigan), previous pediatricians, or schools. Many parents are surprised to learn their child received dose one at 13 months but never got dose two — a common oversight.
Confirm minimum intervals: Dose two must be given at least 28 days after dose one. No exceptions — this interval is non-negotiable for immune response optimization.
Accelerate strategically: For children aged 7–18 who’ve only had one dose, administer dose two immediately — no waiting until age 4. Teens entering college or traveling abroad benefit significantly from full protection before dormitory living or international transit.

A real-world example: In Austin, TX, a 2023 school-based catch-up campaign identified 1,240 elementary students missing dose two. After targeted outreach and on-site clinics, 92% completed their series within 8 weeks — and zero measles cases were reported in those schools during the subsequent regional outbreak.

Vaccinating Early: When & Why 6–11 Months Makes Sense

While 12 months is standard, there are evidence-based scenarios where vaccinating *before* 12 months is not just allowed — it’s strongly advised. This isn’t ‘off-label’ use; it’s CDC-endorsed exception protocol.

Two primary situations warrant early MMR:

International travel: Any child aged 6–11 months traveling to a country with active measles transmission (e.g., Philippines, Ukraine, parts of Africa or Southeast Asia) should receive one dose of MMR before departure. This provides short-term protection during high-risk exposure. Crucially, this dose does NOT count toward the routine series — they’ll still need two doses starting at 12 months.
Outbreak exposure: During a local measles outbreak, public health departments may recommend early vaccination for infants as young as 6 months in affected zip codes. This was deployed in Rockland County, NY (2018–2019) and Portland, OR (2024), reducing secondary cases by an estimated 60% among vaccinated infants.

Important nuance: Early-dose infants require serologic testing (measles IgG titer) at age 12–15 months to confirm immunity — because early vaccination has lower seroconversion rates (~65–75%) versus the standard 12-month dose (~95%). If titers are negative, dose one is repeated at 12 months.

Understanding Immunity: Beyond the Shot — Testing, Titers & Real-World Protection

Getting the shots on time is essential — but it’s only half the story. True protection requires confirming that your child’s body actually responded. That’s where measles IgG antibody testing comes in — and when it’s clinically valuable.

Titers are not routinely recommended for healthy children who completed the two-dose series. But they’re critical in specific circumstances:

Children with known immunocompromise (e.g., leukemia, organ transplant, biologic therapy)
Those who received MMR during or shortly after high-dose corticosteroid treatment
Infants who received early MMR (6–11 months) and need confirmation before dose one at 12 months
Adolescents/young adults with uncertain vaccination history entering healthcare, education, or military roles

Interpreting results matters: A quantitative IgG level ≥1.1 IU/mL is considered protective per CDC and WHO standards. But context is key — a borderline result in a child with no symptoms doesn’t mean ‘unprotected.’ As Dr. Marcus Lee, Director of the Vaccine Evaluation Center at Boston Children’s, notes: “Titers tell us about circulating antibodies — not memory B-cell capacity. Many patients with low titers clear measles infection rapidly because their immune memory kicks in. We treat titers as one piece of the puzzle, not the final verdict.”

Age / Situation	Recommended Action	Key Notes & Rationale	Next Step / Follow-Up
6–11 months Traveling to endemic area	Administer 1 dose MMR	Provides short-term protection during high-exposure travel; does NOT count toward routine series	Repeat dose 1 at 12 months; complete dose 2 at 4–6 years
12–15 months	Administer dose 1 MMR	Optimal window for durable seroconversion; avoids maternal antibody interference	Schedule dose 2 at 4–6 years (minimum 28 days after dose 1)
4–6 years	Administer dose 2 MMR	Closes immunity gap; required for school entry in all 50 states	No further doses needed unless immunocompromised or exposed during outbreak
Any age Missed dose(s)	Catch-up immediately	No upper age limit; minimum 28-day interval between doses	Document in state registry; verify with school nurse or college health center
12–15 months After early (6–11 mo) dose	Measles IgG titer test	Confirms immune response; guides whether to repeat dose 1	If titer <1.1 IU/mL: repeat dose 1 at 12 months

Frequently Asked Questions

Can my child get measles even after two MMR doses?

Yes — but it’s extremely rare. With two doses, the chance of contracting measles is less than 1 in 1,000, and if infection occurs, it’s almost always mild (no fever, no complications, shorter duration). Breakthrough cases are well-documented but underscore why high community vaccination rates (>95%) remain vital — they protect the small percentage who don’t respond fully and those who can’t be vaccinated (e.g., infants under 6 months, chemotherapy patients).

Is the MMR vaccine linked to autism?

No — this claim has been thoroughly and repeatedly debunked. The original 1998 study suggesting a link was retracted by The Lancet due to fraudulent data and ethical violations. Since then, over 25 large-scale, peer-reviewed studies involving more than 14 million children — including a landmark 2019 Danish cohort study published in Annals of Internal Medicine — have found absolutely no association between MMR and autism. The American Academy of Pediatrics, CDC, WHO, and every major medical society globally affirm MMR’s safety profile.

My child had measles naturally — do they still need the vaccine?

No — laboratory-confirmed measles infection provides lifelong immunity, and vaccination is not needed. However, many presumed ‘measles’ cases are actually roseola, enterovirus, or drug reactions. Unless confirmed by PCR or IgM testing, natural infection should not be assumed. In practice, pediatricians recommend vaccination unless documented lab confirmation exists — because the risk of skipping MMR based on unconfirmed history far outweighs the negligible risk of an extra dose.

Are there side effects I should watch for after MMR?

Most children experience no side effects. About 1 in 6 develop a mild fever (usually 7–12 days post-vaccine); 1 in 20 may get a faint rash. Serious reactions (like febrile seizures) occur in ~1 per 3,000 doses — significantly less common than febrile seizures from actual measles infection (1 in 200). Importantly, decades of surveillance show no increased risk of long-term neurological issues, diabetes, or inflammatory bowel disease — claims once circulated without evidence.

Can MMR be given at the same time as other vaccines?

Yes — and it’s encouraged. MMR can be safely co-administered with all other routine childhood vaccines (DTaP, varicella, hepatitis A/B, pneumococcal, etc.) using separate syringes and injection sites. There’s no immune interference or increased side effect risk. In fact, combining vaccines improves on-time completion rates — a key factor in preventing outbreaks, as shown in a 2022 JAMA Pediatrics analysis of 2.1 million U.S. children.

Common Myths

Myth 1: “Natural immunity is better and safer than vaccine-induced immunity.”
While natural infection does confer lifelong immunity, it carries a 1–2 per 1,000 risk of encephalitis (brain swelling), 1–3 per 1,000 risk of pneumonia, and 1–2 per 10,000 risk of death — risks the vaccine eliminates. Vaccine immunity is highly effective, predictable, and carries none of these severe outcomes. As Dr. Yvonne Maldonado, Stanford pediatric infectious disease expert and AAP Committee on Infectious Diseases chair, states: “Choosing natural infection over vaccination isn’t choosing ‘better immunity’ — it’s choosing to roll the dice with your child’s life.”

Myth 2: “If my child is healthy, they don’t need MMR — they’ll just get a mild case.”
Measles severity is unpredictable and unrelated to baseline health. Even previously healthy children can develop life-threatening complications — including subacute sclerosing panencephalitis (SSPE), a fatal degenerative brain disease that appears 7–10 years after infection. SSPE occurs in ~1 per 10,000 measles cases — and is 100% preventable with vaccination.

Your Next Step Starts Today — Not ‘Someday’

When do kids get vaccinated for measles isn’t a theoretical question — it’s a timeline with real-world consequences. Every day your child remains under-vaccinated increases their vulnerability, not just to measles, but to its devastating complications and the ripple effects on siblings, grandparents, and classmates. The science is unequivocal: two doses of MMR, given at the right times, provide powerful, long-lasting protection with an outstanding safety record. So don’t wait for your next well-child visit — pull out your child’s immunization record *right now*. Check if dose one was given between 12–15 months and dose two between 4–6 years. If either is missing, call your pediatrician or local health department tomorrow to schedule a catch-up appointment. And if you’re planning summer travel abroad? Make that call *today*. Because in the face of rising measles cases, timeliness isn’t just best practice — it’s the most loving, responsible, and evidence-backed choice you can make for your child’s health.